SEC Form 4 · accession 0001127602-19-005980

LABCORP HOLDINGS INC. · LH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Financial Officer, EVP

Period of report

Feb 12, 2019

Accepted (ET)

Feb 14, 2019 · 4:05 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000920148

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	Feb 12, 2019	M	780	—	A	20,467	D
Common Stock	Feb 12, 2019	F	232	$146.59	D	20,235	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Restricted Stock Unit^F4,F1,F3	—	Feb 12, 2019	M	780	D	—	—	Common Stock	780	2,554	D
Restricted Stock Unit^F4,F1,F5	—	Feb 12, 2019	A	2,820	A	—	—	Common Stock	2,820	5,374	D
Non-qualified Stock Options^F6,F7	$146.59	Feb 12, 2019	A	11,600	A	Feb 12, 2020	Feb 11, 2029	Common Stock	11,600	11,600	D

F1Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
F2Stock withholding to satisfy tax withholding obligations.
F3The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on 2/12/19.
F4This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
F5The Restricted Stock Units vest in three equal annual installments beginning on 2/12/2020.
F6Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan.
F7The option vests in three equal installments beginning on the date reflected in this column.